Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Butazolidin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1975
1975
  • G. Krook
  • Contact dermatitis
  • 1975
  • Corpus ID: 20350152
One case of fixed drug eruption caused by oxyphenbutazone with cross-sensitivity to phenylbutazone has been reported (Nayyar… Expand
Is this relevant?
Highly Cited
1955
Highly Cited
1955
Two metabolic products of phenylbutazone have been isolated from the urine of subjects receiving the drug. One of them… Expand
Is this relevant?
Highly Cited
1954
Highly Cited
1954
Abstract 1. 1. Phenylbutazone exhibits antirheumatic effects in rheumatoid arthritis which are comparable to those shown by… Expand
Is this relevant?
1954
1954
IN THE medical management of thrombophlebitis, reliance is placed almost completely on bed rest with elevation of the extremity… Expand
Is this relevant?
Highly Cited
1953
Highly Cited
1953
1. A method is described for the estimation of phenylbutazone in biological fluids and tissues. 2. Phenylbutazone is rapidly and… Expand
Is this relevant?
1953
1953
There have been several reports in the literature recently concerning the beneficial effects of phenylbutazone (butazolidin®) in… Expand
Is this relevant?
1953
1953
Extensive clinical trial has shown that phenylbutazone (Butazolidin) is effective in relieving pain and stiffness in such… Expand
Is this relevant?
Highly Cited
1952
Highly Cited
1952
Phenylbutazone (butazolidin®) is one of a group of pyrazole derivatives developed by the chemists of the J. R. Geigy Co., of… Expand
Is this relevant?
1952
1952
Studies in Europe on parenteral use of aminopyrine necessitated the development of a solvent, and a pyrazol synthetic derivative… Expand
Is this relevant?